1. CDC. COVID-19: science brief: emerging SARS-CoV-2 variants. Atlanta, GA: US Department of Health and Human Services, CDC; 2021. Accessed February 16, 2021. https://www.cdc.gov/coronavirus/2019-ncov/more/science-and-research/scientific-brief-emerging-variants.html
2. O’Toole Á, Hill V. B.1.351. Edinburgh, Scotland: Rambaut Group; 2021. https://cov-lineages.org/global_report_B.1.351.html
3. Tegally H, Wilkinson E, Giovanetti M, Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa. medRxiv [Preprint posted online December 22, 2020]. https://www.medrxiv.org/content/10.1101/2020.12.21.20248640v1
4. Wang P, Liu L, Iketani S, Increased resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7 to antibody neutralization. bioRxiv [Preprint posted online January 26, 2021].https://www.biorxiv.org/content/10.1101/2021.01.25.428137v2
5. Madhi SA, Baillie V, Cutland CL, Safety and efficacy of the ChAdOx1 nCoV-19 (AZD1222) Covid-19 vaccine against the B.1.351 variant in South Africa. medRxiv [Preprint posted online February 12, 2021].https://www.medrxiv.org/content/10.1101/2021.02.10.21251247v1